Contributing to the development of our guidelines
We've created the guides and resources on this page to help people who are involved in developing our guidelines.
Contributing to a medicines evaluation: help for patients and carers
Information for national patient and carer organisations
These guides support national patient and carer organisations and patient experts involved in NICE technology appraisals.
We also offer monthly, hour long Zoom inductions for patient and carer organisations. Whether you already work with us or are new to working with us, you're welcome to join one of these sessions.
To find out more or to book a place, contact us on 0161 870 3020 or email pacn@nice.org.uk.
A set of guides:
an overview of NICE technology appraisals - factsheet for parent and carer organisations (Word)
scoping NICE technology appraisals - factsheet for parent and carer organisations (Word)
developing NICE technology appraisals - factsheet for parent and carer organisations (Word)
nominating patient experts - a factsheet for parent and carer organisations (Word).
Submitting evidence to a NICE medicines evaluation
You can provide evidence on behalf of your organisation using the submission template. In the guide below we have pulled together advice on gathering and presenting the information, as well as what to avoid.
If you would like advice on preparing for a submission, or for us to read a draft of your submission, contact us on 0161 870 3020 or email pacn@nice.org.uk.
Information for patient experts
This document contains information for patient experts on how to prepare for the meeting and what to expect.
A guide for preparing to be a patient expert (Word).
If you are a patient expert at a committee meeting, you have the opportunity to submit a personal statement before the meeting. This is so that you can tell the committee about your experience of the condition and treatments using our template for patient experts.
Further information
You can read developing NICE guidelines: how to get involved to find out more.